Question 1

Does Steward Partners Investment Advisory own ARQT stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Steward Partners Investment Advisory holds 500 shares of ARQT (Arcutis Biotherapeutics), worth $13,110.

Question 2

How many shares of ARQT does Steward Partners Investment Advisory own?

Accepted Answer

As of its Q2 2026 13F, Steward Partners Investment Advisory holds 500 shares of ARQT (Arcutis Biotherapeutics).

Question 3

What is Steward Partners Investment Advisory's ARQT position worth?

Accepted Answer

As of its Q2 2026 13F, Steward Partners Investment Advisory's ARQT position is worth $13,110.

Question 4

Is Steward Partners Investment Advisory buying or selling ARQT?

Accepted Answer

In Q2 2026, Steward Partners Investment Advisory reduced its ARQT position by 113 shares (-18.4%).

Question 5

When did Steward Partners Investment Advisory first buy ARQT?

Accepted Answer

Steward Partners Investment Advisory first reported ARQT in its Q2 2021 13F and has listed it in 12 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	500	-18.4%	$13,110	0.0%	$26.22	0
2026-Q1	Increased	613	+442.5%	$14,442	0.0%	$23.56	29
2025-Q4	Unchanged	113	0.0%	$3,282	0.0%	$29.04	0
2025-Q3	Unchanged	113	0.0%	$2,130	0.0%	$18.85	0
2025-Q2	New	113	—	$1,584	0.0%	$14.02	17
2025-Q1	Exited	0	-100.0%	$0	0.0%	$15.64	0
2024-Q4	Unchanged	200	0.0%	$2,786	0.0%	$13.93	0
2024-Q3	Unchanged	200	0.0%	$1,860	0.0%	$9.30	0